bioRxivDevelopmental BiologyPreprint
Flexible oocyte manipulation with delayed maturation and improved SCNT efficiency using induced pluripotent stem cells
Luis Henrique de AguiariD, Yoke Lee Lee, Abdallah W. AbdelhadyiD, Prasanthi P. KogantiiD, Vimal SelvarajiD, Soon Hon CheongiD
Abstract
Somatic cell nuclear transfer (SCNT) remains inefficient, limiting its practical use in cattle reproduction and research. This study investigated two complementary strategies to enhance handmade cloning (HMC): (1) holding bovine oocytes overnight and delaying maturation to enable a second round of SCNT and (2) using bovine-induced pluripotent stem cells (biPSCs) as donor nuclei to enhance developmental competence. Bovine oocytes were subjected to either conventional in vitro maturation (CONV; 20 h) or delayed maturation using a holding medium for 20 h before CONV (HOLD). Matured oocytes were used for SCNT, parthenogenetic activation (PA), or in vitro fertilization (IVF) as controls. Handmade SCNT embryos were reconstructed using fibroblasts or biPSCs as donors, activated, and cultured for 7 days. Results showed no significant differences between CONV and HOLD groups in oocyte maturation, recovery after stripping, survival after zona removal, or cleavage and blastocyst development after SCNT. Fusion rates using fibroblasts were comparable between groups (42.6{+/-}6.0% vs. 50.3{+/-}9.8%), with biPSCs showing significantly higher fusion rates in CONV group (85.7{+/-}8.2% vs. 50.5{+/-}8.8%, P<0.05). Among fused embryos, biPSCs produced higher blastocyst rates (33.3{+/-}16.7%) compared with fibroblast donors (21.9{+/-}12.6%, P<0.05). Across all reconstructed embryos, cleavage and blastocyst development were also greater with biPSCs (odds ratios 3.4 and 2.7 respectively). These findings indicate that delaying maturation offers flexible timing for SCNT without compromising competence. Moreover, biPSCs enhance embryo developmental outcomes, supporting their use as superior donor cells for advancing cloning efficiency and applications in reproductive biotechnology.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Human induced pluripotent stem cell-derived ovarian support cell co-culture improves oocyte maturation in vitro after abbreviated gonadotropin stimulation
Sabrina Piechota, Maria Marchante, … Christian Clark Kramme·Human ReproductionPeer-reviewed·Sep 26, 2023
- Improved rescue of immature oocytes obtained from conventional gonadotropin stimulation cycles via human induced pluripotent stem cell-derived ovarian support cell co-culture
Alexa Giovannini, Sabrina Piechota, … Christian Clark Kramme·bioRxiv·Mar 27, 2023
- Reproducible differentiation of pure ovarian support cells from clinical-grade hiPSCs as a novel infertility treatment
Bruna da Silveira Paulsen, Ferran Barrachina, … Christian Clark Kramme·bioRxiv·Apr 29, 2024
- Modulation of sperm capacitation enhances blastocyst hatching in bovine in vitro fertilization
Olinda Briski, Fernanda Fagali Franchi, … Darío Krapf·bioRxiv·Mar 20, 2026
- Ovarian support cell in vitro maturation (OSC-IVM) results in healthy murine live births with no evidence of reprotoxicology in a multigenerational study
Maria Marchante, Ferran Barrachina, … Christian Clark Kramme·Reproductive BioMedicine OnlinePeer-reviewed·Oct 28, 2024
- Direct synthesis of self-organized blastocyst-like cysts derived from human pluripotent stem cells
X. Wen, S. Terada, … K.-i. Kamei·bioRxiv·Nov 26, 2019